Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Trastuzumab Without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients: Randomized Controlled Trial

NCT01104935 is registered in ClinicalTrials.gov with Comprehensive Support Project for Oncology Research as lead sponsor.

NCT NCT01104935
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01104935 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Trastuzumab Without Chemotherapy as a Postoperative Adjuvant Therapy in HER2 Positive Elderly Breast Cancer Patients: Randomized Controlled Trial
Lead sponsor
Comprehensive Support Project for Oncology Research
Phase
Phase 3
Overall status
Completed
Start date
October 28, 2009
Completion date
October 15, 2018
Enrollment
275 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer